WallStreetZenWallStreetZen

NYSE: JNJ
Johnson & Johnson Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnershipStatistics

Analyst price target for JNJ

Based on 9 analysts offering 12 month price targets for Johnson & Johnson

Min Forecast
$153.00-13.38%
Avg Forecast
$173.11-2%
Max Forecast
$190.00+7.56%

Should I buy or sell JNJ stock?

Based on 9 analysts offering ratings for Johnson & Johnson.

Buy
Strong Buy
2 analysts 22.22%
Buy
2 analysts 22.22%
Hold
5 analysts 55.56%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their JNJ stock forecasts and price targets.

JNJ stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-07-17Find Out Why
lockedlocked$00.00+00.00%2025-07-17
lockedlocked$00.00+00.00%2025-07-17Find Out Why
lockedlocked$00.00+00.00%2025-07-17Find Out Why
lockedlocked$00.00+00.00%2025-07-17Find Out Why
Bank of America
Top 29%
72
HoldMaintains$175.00-0.93%2025-07-17Find out why
Leerink Partners
Top 10%
91
HoldDowngrades$153.00-13.38%2025-05-13Find out why
Raymond James
Top 14%
87
BuyMaintains$164.00-7.16%2025-04-16Find out why
Goldman Sachs
Bottom 45%
45
Strong BuyUpgrades$172.00-2.63%2025-04-09Find out why

1 of 1

Forecast return on equity

Is JNJ forecast to generate an efficient return?

Company
40.54%
Industry
-1,983.93%
Market
-47.51%
JNJ's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is JNJ forecast to generate an efficient return on assets?

Company
16.45%
Industry
22.57%
JNJ is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

JNJ earnings per share forecast

What is JNJ's earnings per share in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$10.86+15.41%
Avg 2 year Forecast
$11.36+20.73%
Avg 3 year Forecast
$12.21+29.78%
JNJ's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

JNJ revenue forecast

What is JNJ's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$93.4B+3.07%
Avg 2 year Forecast
$97.2B+7.23%
Avg 3 year Forecast
$102.0B+12.6%
JNJ's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

JNJ earnings growth forecast

How is JNJ forecast to perform vs Drug Manufacturers - General companies and vs the US market?

Company
8.8%
Industry
31.75%
Market
15.23%
JNJ's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
JNJ's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
JNJ's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

JNJ revenue growth forecast

How is JNJ forecast to perform vs Drug Manufacturers - General companies and vs the US market?

Company
3.96%
Industry
6.39%
Market
10.92%
JNJ's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
JNJ's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

JNJ vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
JNJ$176.64$173.11-2.00%Buy
ABBV$206.69$222.60+7.70%Buy
AZN$79.17N/AN/A
NVS$124.21N/AN/A
MRK$84.21$96.17+14.20%Hold
View Top General Drug Manufacturer Stocks

Johnson & Johnson Stock Forecast FAQ

Is Johnson & Johnson Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NYSE: JNJ) stock is to Buy JNJ stock.

Out of 9 analysts, 2 (22.22%) are recommending JNJ as a Strong Buy, 2 (22.22%) are recommending JNJ as a Buy, 5 (55.56%) are recommending JNJ as a Hold, 0 (0%) are recommending JNJ as a Sell, and 0 (0%) are recommending JNJ as a Strong Sell.

If you're new to stock investing, here's how to buy Johnson & Johnson stock.

What is JNJ's earnings growth forecast for 2025-2027?

(NYSE: JNJ) Johnson & Johnson's forecast annual earnings growth rate of 8.8% is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 31.75%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.23%.

Johnson & Johnson's earnings in 2025 is $22,661,000,000.On average, 9 Wall Street analysts forecast JNJ's earnings for 2025 to be $26,154,560,150, with the lowest JNJ earnings forecast at $26,082,309,984, and the highest JNJ earnings forecast at $26,347,227,260. On average, 9 Wall Street analysts forecast JNJ's earnings for 2026 to be $27,361,378,759, with the lowest JNJ earnings forecast at $26,371,310,648, and the highest JNJ earnings forecast at $28,129,398,025.

In 2027, JNJ is forecast to generate $29,410,634,305 in earnings, with the lowest earnings forecast at $29,020,483,408 and the highest earnings forecast at $30,007,902,345.

What is JNJ's revenue growth forecast for 2025-2027?

(NYSE: JNJ) Johnson & Johnson's forecast annual revenue growth rate of 3.96% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.39%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.92%.

Johnson & Johnson's revenue in 2025 is $90,627,000,000.On average, 6 Wall Street analysts forecast JNJ's revenue for 2025 to be $224,959,942,876,641, with the lowest JNJ revenue forecast at $224,831,968,565,661, and the highest JNJ revenue forecast at $225,160,417,821,024. On average, 6 Wall Street analysts forecast JNJ's revenue for 2026 to be $234,043,525,175,280, with the lowest JNJ revenue forecast at $231,781,832,465,535, and the highest JNJ revenue forecast at $235,884,750,818,040.

In 2027, JNJ is forecast to generate $245,755,611,868,919 in revenue, with the lowest revenue forecast at $243,616,241,098,822 and the highest revenue forecast at $248,580,309,181,788.

What is JNJ's forecast return on assets (ROA) for 2025-2028?

(NYSE: JNJ) forecast ROA is 16.45%, which is lower than the forecast US Drug Manufacturers - General industry average of 22.57%.

What is JNJ's Price Target?

According to 9 Wall Street analysts that have issued a 1 year JNJ price target, the average JNJ price target is $173.11, with the highest JNJ stock price forecast at $190.00 and the lowest JNJ stock price forecast at $153.00.

On average, Wall Street analysts predict that Johnson & Johnson's share price could fall to $173.11 by Jul 17, 2026. The average Johnson & Johnson stock price prediction forecasts a potential downside of 2% from the current JNJ share price of $176.64.

What is JNJ's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: JNJ) Johnson & Johnson's current Earnings Per Share (EPS) is $9.41. On average, analysts forecast that JNJ's EPS will be $10.86 for 2025, with the lowest EPS forecast at $10.83, and the highest EPS forecast at $10.94. On average, analysts forecast that JNJ's EPS will be $11.36 for 2026, with the lowest EPS forecast at $10.95, and the highest EPS forecast at $11.68. In 2027, JNJ's EPS is forecast to hit $12.21 (min: $12.05, max: $12.46).

What is JNJ's forecast return on equity (ROE) for 2025-2028?

(NYSE: JNJ) forecast ROE is 40.54%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.